G6PD and G6PD deficiency: The tafenoquine dose-response relationship for haemolysis in G6PD deficiency is much less well characterised (Rueangweerayut et al., 2017), although the currently recommended dose is considered potentially dangerous in all G6PD deficient individuals, including female heterozygotes who may still have a large proportion of G6PD deficient red cells.